NKTR icon

Nektar Therapeutics
NKTR

Overview Fund Activity

136 hedge funds and large institutions have $1.16B invested in Nektar Therapeutics in 2013 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 51 increasing their positions, 47 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
136
Holders Change
-6
Holders Change %
-4.23%
% of All Funds
3.95%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
17
Increased
51
Reduced
47
Closed
21
Calls
$4.46M
Puts
$4.61M
Net Calls
-$146K
Net Calls Change
-$7.96M

Top Buyers

1
Primecap Management
1
Primecap Management
California
$142M
2
First Trust Advisors
2
First Trust Advisors
Illinois
$49M
3
State Street
3
State Street
Massachusetts
$48.9M
4
Bank of New York Mellon
4
Bank of New York Mellon
New York
$38.2M
5
GIM
5
Granahan Investment Management
Massachusetts
$36.6M

Top Sellers

1
MG
1
Meditor Group
Bermuda
$0
2
AG
2
Artal Group
Luxembourg
$18.2M
3
PC
3
PointState Capital
New York
$0
4
ICM
4
IronBridge Capital Management
Illinois
$0
5
Barclays
5
Barclays
United Kingdom
$260K
Name Holding Trade Value Shares
Change 		Shares
Change %
Two Sigma Investments
151
Two Sigma Investments
New York
– -$159K -1,014 Closed
CAM
152
Capstone Asset Management
Texas
– -$137K -874 Closed
PP
153
Paloma Partners
Connecticut
– -$105K -667 Closed
QIM
154
Quantitative Investment Management
Virginia
– -$104K -667 Closed
FANJ
155
Financial Architects (New Jersey)
New Jersey
– -$31K -200 Closed
SO
156
STRS Ohio
Ohio
– -$14K -87 Closed
PG
157
PEAK6 Group
Illinois
– -$5.01K -60 Closed
3 4 5 6
7